• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

土耳其伊兹密尔健康个体中的风疹血清流行率。

Rubella seroprevalence among healthy individuals in Izmir, Turkey.

作者信息

Kurugöl Zafer, Midyat Levent, Türkoğlu Ebru, Ozacar Tijen

机构信息

Department of Pediatrics, Ege University Faculty of Medicine, Izmir, Turkey.

出版信息

Hum Vaccin. 2011 Sep;7(9):972-5. doi: 10.4161/hv.7.9.16370. Epub 2011 Sep 1.

DOI:10.4161/hv.7.9.16370
PMID:21860258
Abstract

In order to assess immunity to rubella in Izmir, Turkey, a total of 600 persons of 1-70 years of age were selected with cluster sampling. Of the 597 subjects, 120(20.1%) was susceptible to the rubella according to their serum antibody levels. Of children 1 to 6 years of age, 50.9% was found to be serologically susceptible to rubella. Rubella protection rates showed a age-related increase, reaching maximum in the 15-19 age group, in which 98.1% of these subjects had antibody titre above the full protective level. Of the 126 females in the reproductive age group, only 4(3.1%) were found to be serologically susceptible to rubella. Logistic regression analysis showed that among the several independent variables, only age (p< 0.001) was significantly associated with rubella protective antibody levels. Epidemiological studies should continue as the epidemiological characteristics of the disease may change depending on the uptake of MMR vaccination.

摘要

为评估土耳其伊兹密尔地区人群的风疹免疫力,采用整群抽样法共选取了600名年龄在1至70岁之间的人员。在这597名受试者中,根据血清抗体水平,有120人(20.1%)对风疹易感。在1至6岁的儿童中,发现50.9%的儿童血清学上对风疹易感。风疹保护率呈现出与年龄相关的增长趋势,在15至19岁年龄组达到最高,该年龄组中98.1%的受试者抗体滴度高于完全保护水平。在126名育龄期女性中,仅发现4人(3.1%)血清学上对风疹易感。逻辑回归分析表明,在几个独立变量中,只有年龄(p<0.001)与风疹保护性抗体水平显著相关。由于疾病的流行病学特征可能会因麻疹、腮腺炎和风疹联合疫苗(MMR)接种率的变化而改变,因此流行病学研究应继续进行。

相似文献

1
Rubella seroprevalence among healthy individuals in Izmir, Turkey.土耳其伊兹密尔健康个体中的风疹血清流行率。
Hum Vaccin. 2011 Sep;7(9):972-5. doi: 10.4161/hv.7.9.16370. Epub 2011 Sep 1.
2
Age-specific rubella seroprevalence in unvaccinated adolescents in Ankara, Turkey.土耳其安卡拉未接种疫苗青少年中特定年龄的风疹血清阳性率
East Mediterr Health J. 2008 Sep-Oct;14(5):1036-43.
3
Seroprevalence of rubella among Turkish women and children in Afyonkarahisar, Turkey.土耳其阿菲永卡拉希萨尔地区土耳其妇女和儿童中风疹的血清流行率。
Turk J Pediatr. 2009 Nov-Dec;51(6):534-8.
4
Rubella Seroprevalence among the General Population in Dongguan, China.中国东莞普通人群中的风疹血清流行率
Jpn J Infect Dis. 2015;68(3):192-5. doi: 10.7883/yoken.JJID.2014.255. Epub 2014 Dec 24.
5
[Age-related seroprevalence of measles, mumps and rubella antibodies in 1996].[1996年麻疹、腮腺炎和风疹抗体的年龄相关血清流行率]
Schweiz Med Wochenschr. 1998 Apr 25;128(17):649-57.
6
Rubella seroprevalence in an unvaccinated population in Izmir: recommendations for rubella vaccination in Turkey.伊兹密尔未接种疫苗人群中的风疹血清流行率:土耳其风疹疫苗接种建议
Pediatr Infect Dis J. 1999 Jul;18(7):577-80. doi: 10.1097/00006454-199907000-00003.
7
Seroepidemiology of rubella virus infection among female residents on the offshore islets of Taiwan.台湾离岛地区女性居民风疹病毒感染的血清流行病学研究
J Trop Med Hyg. 1994 Apr;97(2):75-80.
8
Seroprevalence of rubella among Jordanian women of childbearing age.约旦育龄妇女中风疹的血清流行率。
Vaccine. 2007 May 4;25(18):3615-8. doi: 10.1016/j.vaccine.2007.01.058. Epub 2007 Jan 23.
9
Age specific rubella seroprevalence of an unvaccinated population of adolescents in Ankara, Turkey.土耳其安卡拉未接种疫苗的青少年人群中特定年龄的风疹血清阳性率。
Jpn J Infect Dis. 2003 Feb;56(1):23-5.
10
Rubella seroprevalence in women in the reproductive period, Mersin, Turkey.土耳其梅尔辛育龄期女性的风疹血清流行率
Vaccine. 2007 Jan 15;25(5):912-7. doi: 10.1016/j.vaccine.2006.09.033. Epub 2006 Oct 6.

引用本文的文献

1
Seroepidemiological study of rubella in Vojvodina, Serbia: 24 years after the introduction of the MMR vaccine in the national immunization programme.塞尔维亚伏伊伏丁那地区风疹的血清流行病学研究:国家免疫规划中引入麻疹-腮腺炎-风疹联合疫苗 24 年后。
PLoS One. 2020 Jan 13;15(1):e0227413. doi: 10.1371/journal.pone.0227413. eCollection 2020.